Please login to the form below

Not currently logged in
Email:
Password:

EFPIA director general Richard Bergström resigns

Will remain in the role until a successor has been selected

EFPIA Richard BergstromRichard Bergström, director general of The European Federation of the Pharmaceutical Industries and Associates (EFPIA), has resigned his post.

Described by the EFPIA's president Joe Jimenez as “the voice of the pharmaceutical industry in Europe for the past five years”, Bergström was appointed as director general in 2011, succeeding Brian Ager.

Bergström brought almost 20 years of pharmaceutical industry experience to the role, having started out as a pharmacist before holding a number of senior positions in regulatory affairs for Novartis and Roche.

He had been a member of the EFPIA board for a number of years prior to taking on the top job, joining the association from Swedish research-based pharmaceutical association LIF where he served as its director general.

Commenting on his decision to resign, Bergström said: “I am proud to leave EFPIA at a time when we have developed policies that promote innovation and patient access, such as through the focus on outcomes and on adaptive pathways to speed up the development of new medicines.

“After 15 fantastic years leading industry associations in Sweden and in Brussels, it is time for me to take on a fresh challenge.”

Led by Bergström, the search for his replacement is underway, and he has committed to continuing on as director general until a successor has been identified.

2nd September 2016

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics